HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Erox

This article was originally published in The Rose Sheet

Executive Summary

Erox: Net sales for 1995 increase eight-fold to $9 mil. from $1.1 mil. a year ago, the firm announced Feb. 8. The firm also reduced its net loss to $983,000 from $2.2 mil. in 1995. Erox attributes its turnaround to the company's sole product line -- Realm fragrance and toiletries -- which uses human pheremone technology. The success of the fragrance line "has set the stage" for continued expansion in the U.S. and a "more aggressive approach" to launching the scents outside the U.S. in 1996, according to the company. Currently, the Realm scents are available in about 400 doors, including Bloomingdale's, Macy's East and Dayton Hudson/Marshall Field's...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002509

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel